Collegium Pharmaceutical (COLL) Assets Average (2015 - 2026)

Collegium Pharmaceutical's Assets Average history runs 12 years deep, the most recent figure standing at $1.7 billion for Q1 2026.

• In Q1 2026, Assets Average changed 0.42% year-over-year to $1.7 billion; the TTM figure through Mar 2026 stood at $1.7 billion (changed 0.42% YoY), while the FY2025 annual figure was $1.7 billion, up 18.3% from the prior year.
• Assets Average was $1.7 billion for Q1 2026 at Collegium Pharmaceutical, up from $1.6 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $1.7 billion in Q1 2026 to a low of $969.1 million in Q1 2022.
• Historically, Assets Average has averaged $1.3 billion across 5 years, with a median of $1.2 billion in 2022.
• The sharpest annual moves came in 2022 and 2024: Assets Average surged 83.24% in 2022, then retreated 10.73% in 2024.
• A 5-year view of Assets Average shows it stood at $1.2 billion in 2022, then declined by 2.28% to $1.2 billion in 2023, then jumped by 42.13% to $1.6 billion in 2024, then retreated by 1.05% to $1.6 billion in 2025, then gained by 1.37% to $1.7 billion in 2026.
• The last three Assets Average figures came in at $1.7 billion (Q1 2026), $1.6 billion (Q4 2025), and $1.6 billion (Q3 2025), per Business Quant data.